ELV— Elevance Health, Inc.

FinancialsHospital & Medical Service Plans$86.6B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Premiums	$164.64B+14.2%	$144.17B+0.9%	$142.85B+7.2%	$133.23B
Total operating revenue	$197.58B+12.8%	$175.20B+2.9%	$170.21B+9.3%	$155.66B
Net investment income	$2.19B+7.0%	$2.05B+12.4%	$1.82B+22.9%	$1.49B
Net losses on financial instruments	-$653.0M-46.7%	-$445.0M+35.9%	-$694.0M-26.2%	-$550.0M
Gain on sale of business	$0-100.0%	$201.0M	$0	$0
Total revenues	$199.13B+12.5%	$177.01B+3.3%	$171.34B+9.4%	$156.59B
Benefit expense	$148.22B+16.2%	$127.57B+2.6%	$124.33B+6.6%	$116.64B
Cost of products sold	$21.18B+7.2%	$19.75B+14.2%	$17.29B+32.7%	$13.04B
Operating expense	$20.98B+4.8%	$20.02B-0.3%	$20.09B+13.5%	$17.70B
Interest expense	$1.40B+18.3%	$1.19B+15.0%	$1.03B+21.0%	$851.0M
Amortization of other intangible assets	$628.0M+8.3%	$580.0M-34.5%	$885.0M+15.4%	$767.0M
Total expenses	$192.41B+13.8%	$169.11B+3.4%	$163.63B+9.8%	$149.00B
Income before income tax expense	$6.71B-15.1%	$7.90B+2.4%	$7.71B+1.5%	$7.60B
Income tax expense	$1.05B-45.7%	$1.93B+12.1%	$1.72B+0.7%	$1.71B
Net income	$5.66B-5.2%	$5.97B-0.3%	$5.99B+1.7%	$5.89B
Net loss (gain) attributable to noncontrolling interests	$1.0M-88.9%	$9.0M+325.0%	-$4.0M-166.7%	$6.0M
Shareholders’ net income	$5.66B-5.3%	$5.98B-0.1%	$5.99B+1.6%	$5.89B
Basic (in dollars per share)	$25280000.00-2.1%	$25810000.00+1.7%	$25380000.00+3.3%	$24560000.00
Diluted (in dollars per share)	$25210000.00-1.8%	$25680000.00+1.8%	$25220000.00+3.9%	$24280000.00
Product revenue
Product and service revenue	$24.47B+8.1%	$22.63B+16.3%	$19.45B+29.9%	$14.98B
Service fees

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.